FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894567626> ?p ?o ?g. }

• W2894567626 endingPage "e0204980" @default.
• W2894567626 startingPage "e0204980" @default.
• W2894567626 abstract "Previous research has shown that fibroblast growth factor 2 protein (FGF2) can act as an anxiolytic and anti-depressive agent in rodents. Levels of hippocampal FGF2 and FGF2 receptors are decreased in post-mortem brains of individuals with mood disorders. No changes in FGF2 were noted in the post-mortem brains of individuals with mood disorders that were successfully treated with anti-depressant medication prior to death. Mutations in the FGF2 gene in humans have been shown to predict non-responsiveness to the therapeutic effects of selective serotonin reuptake inhibitors (SSRIs). These findings suggest that FGF2 may potentially be a target of and/or required for the therapeutic effects of antidepressant medications. To test this, we employed a rodent model of depressive behaviour, chronic variable stress (CVS) in conjunction with antidepressant treatment (fluoxetine) in wild-type (WT) and FGF2 knockout mice (FGF2KO) and examined depressive and anxiety behaviors. Results showed that fluoxetine reversed the effects of CVS on depressive and anxiety behaviours in wild-type mice only, suggesting that the FGF2 gene is indeed necessary for the therapeutic effects of fluoxetine. Interestingly, CVS decreased hippocampal FGF2 levels and fluoxetine partially reversed this effect. Because FGF2 has been previously shown to modify HPA activity through hippocampal glucocorticoid receptors (GR), we examined levels of glucocorticoid receptors and found a decrease in GR in response to CVS, with a further decrease in FGF2KO. No effect of fluoxetine on GR was observed in either WT or FGF2KO mice. This suggests that further changes in glucocorticoid receptors are not necessary for the anti-depressant effects of fluoxetine in WT mice, although decreased glucocorticoid receptors in response to FGF2 deletion may preclude the therapeutic actions of fluoxetine in FGF2KO. Whether astroglia, astroglial functions, or HPA changes are the downstream target of FGF2-mediated changes induced by fluoxetine remains to be determined, however, the current study reaffirms the potential of FGF2 as a novel therapeutic target in the treatment of depression and anxiety disorders." @default.
• W2894567626 created "2018-10-12" @default.
• W2894567626 creator A5001284028 @default.
• W2894567626 creator A5005905515 @default.
• W2894567626 creator A5044198912 @default.
• W2894567626 creator A5068516916 @default.
• W2894567626 creator A5076725834 @default.
• W2894567626 creator A5085094407 @default.
• W2894567626 creator A5087594298 @default.
• W2894567626 date "2018-10-01" @default.
• W2894567626 modified "2023-10-06" @default.
• W2894567626 title "Fibroblast growth factor 2 is necessary for the antidepressant effects of fluoxetine" @default.
• W2894567626 cites W1505242816 @default.
• W2894567626 cites W1570428653 @default.
• W2894567626 cites W1770497983 @default.
• W2894567626 cites W1864391669 @default.
• W2894567626 cites W1968707626 @default.
• W2894567626 cites W1969300914 @default.
• W2894567626 cites W1978696776 @default.
• W2894567626 cites W1979623781 @default.
• W2894567626 cites W1982428356 @default.
• W2894567626 cites W1987902229 @default.
• W2894567626 cites W1987972424 @default.
• W2894567626 cites W1996962495 @default.
• W2894567626 cites W2001661745 @default.
• W2894567626 cites W2003469897 @default.
• W2894567626 cites W2003982930 @default.
• W2894567626 cites W2014373387 @default.
• W2894567626 cites W2015112116 @default.
• W2894567626 cites W2025026106 @default.
• W2894567626 cites W2025691192 @default.
• W2894567626 cites W2025894081 @default.
• W2894567626 cites W2060341782 @default.
• W2894567626 cites W2063710526 @default.
• W2894567626 cites W2070307663 @default.
• W2894567626 cites W2083739539 @default.
• W2894567626 cites W2087651921 @default.
• W2894567626 cites W2091845372 @default.
• W2894567626 cites W2091850319 @default.
• W2894567626 cites W2104419150 @default.
• W2894567626 cites W2115614479 @default.
• W2894567626 cites W2127087678 @default.
• W2894567626 cites W2143623498 @default.
• W2894567626 cites W2150092716 @default.
• W2894567626 cites W2154797189 @default.
• W2894567626 cites W2160820499 @default.
• W2894567626 cites W2165526480 @default.
• W2894567626 cites W2170680205 @default.
• W2894567626 cites W2170684975 @default.
• W2894567626 cites W2234783505 @default.
• W2894567626 cites W2291080546 @default.
• W2894567626 cites W2292932763 @default.
• W2894567626 cites W2805957248 @default.
• W2894567626 doi "https://doi.org/10.1371/journal.pone.0204980" @default.
• W2894567626 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6166983" @default.
• W2894567626 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30273396" @default.
• W2894567626 hasPublicationYear "2018" @default.
• W2894567626 type Work @default.
• W2894567626 sameAs 2894567626 @default.
• W2894567626 citedByCount "26" @default.
• W2894567626 countsByYear W28945676262019 @default.
• W2894567626 countsByYear W28945676262020 @default.
• W2894567626 countsByYear W28945676262021 @default.
• W2894567626 countsByYear W28945676262022 @default.
• W2894567626 countsByYear W28945676262023 @default.
• W2894567626 crossrefType "journal-article" @default.
• W2894567626 hasAuthorship W2894567626A5001284028 @default.
• W2894567626 hasAuthorship W2894567626A5005905515 @default.
• W2894567626 hasAuthorship W2894567626A5044198912 @default.
• W2894567626 hasAuthorship W2894567626A5068516916 @default.
• W2894567626 hasAuthorship W2894567626A5076725834 @default.
• W2894567626 hasAuthorship W2894567626A5085094407 @default.
• W2894567626 hasAuthorship W2894567626A5087594298 @default.
• W2894567626 hasBestOaLocation W28945676261 @default.
• W2894567626 hasConcept C118552586 @default.
• W2894567626 hasConcept C126322002 @default.
• W2894567626 hasConcept C134018914 @default.
• W2894567626 hasConcept C148762608 @default.
• W2894567626 hasConcept C15744967 @default.
• W2894567626 hasConcept C170493617 @default.
• W2894567626 hasConcept C2775864247 @default.
• W2894567626 hasConcept C2776134451 @default.
• W2894567626 hasConcept C2777134132 @default.
• W2894567626 hasConcept C2777765862 @default.
• W2894567626 hasConcept C2779144063 @default.
• W2894567626 hasConcept C2779177272 @default.
• W2894567626 hasConcept C2780051608 @default.
• W2894567626 hasConcept C2780841215 @default.
• W2894567626 hasConcept C2781161787 @default.
• W2894567626 hasConcept C558461103 @default.
• W2894567626 hasConcept C59493245 @default.
• W2894567626 hasConcept C71924100 @default.
• W2894567626 hasConcept C98274493 @default.
• W2894567626 hasConceptScore W2894567626C118552586 @default.
• W2894567626 hasConceptScore W2894567626C126322002 @default.
• W2894567626 hasConceptScore W2894567626C134018914 @default.
• W2894567626 hasConceptScore W2894567626C148762608 @default.
• W2894567626 hasConceptScore W2894567626C15744967 @default.

• next